Strive Financial Group’s Sunshine Biopharma SBFM Stock Holding History

Strive Financial Group’s Portfolio SBFM Stock Details SBFM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2	Buy	+1	New	+$6	﹤0.01%	852
2026 Q1	–	Hold	0	–	-$1	–	843
2025 Q4	–	Hold	0	–	–	–	728

Other funds holding SBFM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

CIAM

Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

Strive Financial Group's SBFM Position: Q2 2026 in Review

Strive Financial Group opened a new position in Sunshine Biopharma (SBFM) in Q2 2026: 1 share worth $2. The stake represents ﹤0.01% of the portfolio and ranks #852 among its holdings.

9 funds tracked by Wall St. Rank hold SBFM as of Q2 2026.

Strive Financial Group held 1 share of Sunshine Biopharma worth $2 as of Q2 2026.
Sunshine Biopharma was a new Strive Financial Group position in Q2 2026.
Sunshine Biopharma made up ﹤0.01% of Strive Financial Group's portfolio in Q2 2026, its #852 holding.
9 funds tracked by Wall St. Rank held Sunshine Biopharma as of Q2 2026.

Based on Strive Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.